BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 16, 2006
View Archived Issues
Snapshots: Ceftobiprole results presented at ICAAC
Read More
Studies test in vitro antibacterial activity of retapamulin
Read More
Disease control noted with PTK-787/ZK-222584 in non-small cell lung cancer
Read More
Dose-finding study of weekly ZK-EPO in refractory solid tumors completed
Read More
Phase II data show efficacy of casopitant in chemotherapy-induced nausea/vomiting
Read More
Enrollment completed in morphine study with Hylenex
Read More
Epinastine begins phase II in patients with seasonal allergic rhinitis
Read More
Additional phase III results of telavancin in cSSSI
Read More
Entry blocker peptide demonstrates activity against influenza viruses
Read More
CoDa completes Series A financing
Read More
NitroMed focuses resources on development of BiDil XR
Read More
Ariad grants license to Bellicum for Argent cell-signaling regulation technology
Read More
Immtech advances preclinical pipeline of antimicrobial drug candidates
Read More
Analysis of independent study of CellCept in myasthenia gravis
Read More
Otsuka launching Physuline in Japan
Read More
BiovaxID accepted into E.U. Drug Register for Rare Diseases
Read More
New phase I trial of inhaled formulation of ALN-RSV01
Read More
Adherex regains all rights to ADH-1
Read More
Phase III data for Fentora for breakthrough pain in chronic low back pain patients
Read More
New agents for gastrointestinal disorders described in recent GSK patents
Read More
Recent patents disclose novel agents for obesity and disorders of lipoprotein metabolism
Read More
Recent Janssen patent claims complement C1s inhibitors for autoimmune disorders
Read More
Nexium approved for treatment of Zollinger-Ellison syndrome
Read More
New indication sought for Herceptin in Europe
Read More
NDA filed for Sanctura XR in overactive bladder
Read More
Elan reports on the antihyperalgesic effects of their novel B1 receptor antagonist, ELN-441958
Read More
Preclinical activity of the novel antipsychotic RGH-188
Read More